KENNETH GREGORY CHAHINE portrait
  • Professor (Lecturer), College Of Law

Publications

  • Industry opposes genomic legislation. Nature Biotechnology, May;20: 419 (2002). Published, 05/2002.
  • Amgen preserves erythropoietin monopoly for now. Nature Biotechnology, Mar;19: 188 (2001). Published, 03/2001.
  • Hatch-Waxman changes debated. Nature Biotechnology, Jul;18: 710-1(2000). Published, 07/2000.
  • Amgen battles for EPO in Congress. Nature Biotechnology, Nov;16:999-1000 (1998). Published, 11/1998.
  • The importance of "legalese" in biotechnology patents. Nature Biotechnology, Oct;16: 971-2(1998). Published, 10/16/1998.
  • Building the proper foundation for genomic based patents, Nature Biotechnology, 16: 683-684 (1998). Published, 07/1998.
  • Cancer prognostic approved. Nature Biotechnology, Feb;16:121(1998). Published, 02/1998.
  • All clear for HIV-targeting ribozyme in phase II. Nature Biotechnology, Feb;16:123(1998). Published, 02/1998.
  • Elanex battles for piece of erythropoietin market, Nature Biotechnology, 16: 16 (1998). Published, 01/1998.
  • US courts disagree on generic exclusivity, Nature Biotechnology, 16: 132 (1998). Published, 01/1998.
  • Patent office resurrects EST debate, Nature Biotechnology, 16: 711 (1998). Published, 01/1998.
  • Genentech sues to protect clot buster market share, Nature Biotechnology, 16: 410 (1998). Published, 01/1998.
  • Enabling DNA and Protein Claims: Why Claiming Biological Equivalents Encourages Innovation, American Intellectual Property Law Association Quarterly Journal, 25(3): 333 (1997). Published, 01/1997.
  • Amgen Protects its Billion Dollar Protein, Nature Biotechnology, 15: 496-497 (1997). Published, 01/1997.
  • Patenting Genes: Just when you thought it was safe, Nature Biotechnology, 15: 586-587 (1997). Published, 01/1997.
  • An Industry in Focus: Utah's Biotechnology Boom, Utah Business, October: 27-31 (1997). Published, 01/1997.
  • Wrangling over the rights to BRAC1, Nature Biotechnology, 15: 936 (1997). Published, 01/1997.
  • Eli Lilly Wins on Appeal, Nature Biotechnology, 15: 823 (1997). Published, 01/1997.
  • University of Colorado wins inventorship dispute with American Cyanamid, Nature Biotechnology, 15: 831 (1997). Published, 01/1997.
  • Going beyond the native: Protecting DNA and protein patents, Nature Biotechnology, 15: 183-185 (1997). Published, 01/1997.
  • Electrical Activity Suppresses Nicotinic Acetylcholine Receptor Gamma Subunit Promoter Activity. Developmental Biology, 168: 416-428 (1995). Published, 01/1995.
  • Calcium Regulates the Expression of the Nicotinic Acetylcholine Receptor Subunit RNAs, Journal of Biological Chemistry, 269: 19447-19456, (1994). Published, 01/1994.
  • Coupling Muscle Electrical Activity to Nicotinic Acetylcholine Receptor Gene Expression Via a Cyclic AMP-Dependent Second Messenger System, Journal of Biological Chemistry, 268, 2893-2898, (1993). Published, 01/1993.
  • A 102 Base Pair Sequence Confers Electrical Regulation on the Nicotinic Acetylcholine Receptor (nAChR) Delta-Subunit, Development, 12 , 123-128, (1992). Published, 01/1992.
  • Molecular and electrophysiological characterization of the allelic variant of the rat alpha-6 GABA-A receptor subunit, Molecular Brain Research, 16, 173-178, (1992). Published, 01/1992.